INSULIN-ANTIBODIES AND INSULIN AUTOANTIBODIES

[41] Atkinson MA, MacLaren NK, Riley WJ, Winter WE, Fisk DD, Spillar RP, Are insulin autoantibodies markers for insulin‐dependent diabetes mellitus?, Diabetes, 35, pp. 894-898, (1986)

[42] Karjalainen J., Knip M., Mustonen A., Ilonen J., Akerblom HK, Relation between insulin antibody and complement‐fixing islet cell antibody at clinical diagnosis of IDDM, Diabetes, 35, pp. 620-622, (1986)

[43] McEvoy, Witt ME, Ginsberg-Fellner F., Rubinstein P., Anti‐insulin antibodies in children with type I diabetes mellitus. Genetic regulation of production and presence at diagnosis before insulin replacement, Diabetes, 35, pp. 634-641, (1986)

[44] Arslanian SA, Becker DJ, Rabin B., Et al., Correlates of insulin antibodies in newly diagnosed children with insulin‐dependent diabetes before insulin therapy, Diabetes, 34, pp. 926-930, (1985)

[45] Wilkin T., Armitage M., Casey C., Et al., Value of insulin autoantibodies as serum markers for insulin‐dependent diabetes mellitus, Lancet, 1, pp. 480-482, (1985)

[46] Wasada T., Eguchi Y., Takayama S., Yao K., Hirata Y., Ishii S., Insulin autoimmune syndrome associated with benign monoclonal gammopathy. Evidence of monoclonal insulin autoantibodies, Diabetes Care, 12, pp. 147-150, (1989)

[47] Diaz J-L, Wilkin T., Differences in epitope restriction of autoantibodies to native human insulin (IAA) and antibodies to heterologous insulin (IA), Diabetes, 36, pp. 66-72, (1987)

[48] Uchigata Y., Yao K., Takayama-Hasumi S., Hirata Y., Human monoclonal IgG1 insulin autoantibody from insulin autoimmune syndrome directed at determinant at asparagine site on insulin B‐chain, Diabetes, 38, pp. 663-666, (1989)

[49] Nell LJ, Hulbert C., Thomas JW, Human insulin autoantibody fine specificity and H and L chain use, J Immunol, 142, pp. 3063-3069, (1989)

[50] Kaplan DR, Possible target antigens in autoimmune endocrine disease, Immunology Today, 5, pp. 130-131, (1984)

[41] Atkinson MA, MacLaren NK, Riley WJ, Winter WE, Fisk DD, Spillar RP, Are insulin autoantibodies markers for insulin‐dependent diabetes mellitus?, Diabetes, 35, pp. 894-898, (1986)

[42] Karjalainen J., Knip M., Mustonen A., Ilonen J., Akerblom HK, Relation between insulin antibody and complement‐fixing islet cell antibody at clinical diagnosis of IDDM, Diabetes, 35, pp. 620-622, (1986)

[43] McEvoy, Witt ME, Ginsberg-Fellner F., Rubinstein P., Anti‐insulin antibodies in children with type I diabetes mellitus. Genetic regulation of production and presence at diagnosis before insulin replacement, Diabetes, 35, pp. 634-641, (1986)

[44] Arslanian SA, Becker DJ, Rabin B., Et al., Correlates of insulin antibodies in newly diagnosed children with insulin‐dependent diabetes before insulin therapy, Diabetes, 34, pp. 926-930, (1985)

[45] Wilkin T., Armitage M., Casey C., Et al., Value of insulin autoantibodies as serum markers for insulin‐dependent diabetes mellitus, Lancet, 1, pp. 480-482, (1985)

[46] Wasada T., Eguchi Y., Takayama S., Yao K., Hirata Y., Ishii S., Insulin autoimmune syndrome associated with benign monoclonal gammopathy. Evidence of monoclonal insulin autoantibodies, Diabetes Care, 12, pp. 147-150, (1989)

[47] Diaz J-L, Wilkin T., Differences in epitope restriction of autoantibodies to native human insulin (IAA) and antibodies to heterologous insulin (IA), Diabetes, 36, pp. 66-72, (1987)

[48] Uchigata Y., Yao K., Takayama-Hasumi S., Hirata Y., Human monoclonal IgG1 insulin autoantibody from insulin autoimmune syndrome directed at determinant at asparagine site on insulin B‐chain, Diabetes, 38, pp. 663-666, (1989)

[49] Nell LJ, Hulbert C., Thomas JW, Human insulin autoantibody fine specificity and H and L chain use, J Immunol, 142, pp. 3063-3069, (1989)

[50] Kaplan DR, Possible target antigens in autoimmune endocrine disease, Immunology Today, 5, pp. 130-131, (1984)